News
-
-
-
COMMUNIQUÉ DE PRESSE
Peer-reviewed study demonstrates LEON’s FR-JET® modular mixer enables stable high-concentration mRNA-LNPs with enhanced in vivo activity
Study in Pharmaceutics shows LEON's FR-JET mixer enables stable high-concentration mRNA-LNPs with enhanced in vivo activity, revolutionizing LNP manufacturing -
-
-
COMMUNIQUÉ DE PRESSE
leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer as company’s products approach market
leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer as company's products approach market. Dr. Hofmann brings 30 years of experience in medicine, corporate strategy, and international management -
-
-
COMMUNIQUÉ DE PRESSE
Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery
Feasibility study confirms LEON's FR-JET technology's exceptional performance in advanced nanoparticle manufacturing for drug delivery, validated by Evonik Canada Inc -
